Filing Details
- Accession Number:
- 0001209191-17-021497
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-17 17:29:39
- Reporting Period:
- 2017-03-16
- Filing Date:
- 2017-03-17
- Accepted Time:
- 2017-03-17 17:29:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1513818 | Versartis Inc. | VSAR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380178 | Shahzad Malik | C/O Advent Life Sciences 158 North Gower Street London X0 X0 NW1 2ND | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-03-16 | 97,303 | $18.50 | 2,007,925 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2017-03-17 | 386,367 | $18.01 | 1,621,558 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 9,200 | Direct |
Footnotes
- The shares were sold at prices ranging from $18.30 to $18.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. The Reporting Person is a partner of Advent, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein.
- The shares were sold at prices ranging from $18.00 to $18.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.